Indian Journal of Dental ResearchIndian Journal of Dental ResearchIndian Journal of Dental Research
Indian Journal of Dental Research   Login   |  Users online:

Home Bookmark this page Print this page Email this page Small font sizeDefault font size Increase font size         


ORIGINAL RESEARCH Table of Contents   
Year : 2017  |  Volume : 28  |  Issue : 2  |  Page : 162-168
Serum Cyfra 21-1 levels in oral squamous cell carcinoma patients and its clinicopathologic correlation

1 Department of Oral Pathology and Microbiology, Government Dental College and Hospital, Aurangabad, Maharashtra, India
2 Department of Dentistry, Vaishampayan Memorial Government Medical College, Solapur, Maharashtra, India

Correspondence Address:
Preeti Singh
Upadhyay Dental Clinic, K-214, Park Plaza, Samta Gotri Road, Subhanpura, Vadodara, Gujarat
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0970-9290.207789

Rights and Permissions

Background: Oral squamous cell carcinoma(OSCC) is the most common malignant tumor in the oral and maxillofacial region. The diagnosis in most cases is made at advanced stages with lymph node metastases and thus has a poor prognosis. Evidence suggests that detection of molecular abnormalities might be useful in screening for early malignancy. Cytokeratins(CKs) are part of the epithelial cytoskeleton. In malignancy, some CK filament fragments might be released in the serum. CK19 fragment Cyfra 21-1 is useful tumor marker for squamous cell carcinoma, but its clinical value in OSCC has not been confirmed. Hence, the aim was to investigate the diagnostic value of serum Cyfra 21-1 in OSCC patients. Materials and Methods: The preoperative serum Cyfra 21-1 concentration of forty OSCC patients and forty healthy controls was detected by enzyme-linked immunosorbent assay(ELISA) using a commercial Cyfra 21-1 ELISA kit Xema Co., Ltd., Moscow, Russia. All statistical analyses were performed on STATISTICA statistical software(Windows version6.0). Results: There was a statistically significant difference(P<0.001) of mean serum Cyfra 21-1 levels(ng/mL) between OSCC cases(1.76±0.81) and healthy controls(0.43±0.14). The difference between controls and Stage III and Stage IV was also statistically significant(P<0.001). The mean serum Cyfra 21-1 level was lower in histopathological Grade I cases(1.72±0.78) than Grade II(2.04±1.13), but the difference was not statistically significant(P=0.459). Conclusion: It could thus be conjectured from the present study that increased serum Cyfra 21-1 level can be used as an adjunctive serological marker for the OSCC disease staging.

Print this article     Email this article

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
  Citation Manager
 Access Statistics
  Reader Comments
  Email Alert *
  Add to My List *

 Article Access Statistics
    PDF Downloaded121    
    Comments [Add]    
    Cited by others 8    

Recommend this journal